Latest LJPC reports update at 2022-08-15: 2022-Q22022-Q12021-Q4
La Jolla Pharmaceutical Company logo

La Jolla Pharmaceutical Company LJPC

$ 6.2 0.0%

Country

usaUSA

IPO year

1994

Industry

Biotechnology

Stock Exchange

NASDAQ CAPITAL

CEO

Dr. George Tidmarsh

Employees in the company

90

Shares

27.4 M

Market Cap[1]

$ 154 M

EBITDA (LTM)

$ 1.73 M

P/E (LTM)

8.99

P/S (LTM)

3.07

EPS (LTM)

0.69

Other stocks of industry "Biotechnology"

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.